The present invention relates to replication protein A (RPA)
transcriptional factors. There is provided a nucleotide sequence encoding
a replication protein A transcriptional activator 1 (RTB1) and a protein
encoded by such a nucleotide sequence. RBT1 has a high activity and is
highly transactivated in cancer cells. The sequence may be used to treat
neoplastic disorders and in gene therapy.